Have you tried out BAD BEAT Investing? Not only is it a free trial, but this week you can take 65% off the total price that market pros are paying to access the site at the full $924 per year rate. Yours for ~$1 a day. Why bother?
Not only do we spot great deep value long ideas, with winners such as (T) and (PM) spotted at $28 and $68 respectively, but we provide short-term, rapid return trade ideas each week as well. This come in the forms of articles, such as recommending (FNKO) at $13.76, or (HL) at $1.45, but also in our very vibrant chat, where some of the best ideas emerge from our community of hundreds of traders. When ideas are so rapid that we cannot devote the 4-8 hours to craft an in depth analysis, we put trade ideas out on the chat.
We recently pegged (ACB) at $2.30, and ran it to over $3.00 in 2 days, a return of 30%-plus.
The stock was having a true issue with credibility because the company reported a second consecutive quarter of disappointing results. After missing guidance last quarter, the company announced that it is suspending construction of its two gigantic greenhouses and it is also lowering the conversion price of its 2020 converts to save cash. With its operations still unprofitable and cash balance dwindling, the market punished it. We felt at $2.30 this had gone too far, too fast:
This call quickly was scooped up by some members:
Our chat service is vibrant and we are available all day during market hours to help you learn and grow. Want to hit homeruns? Come get in the game with this Black Friday deal
Black Friday Week Special: Secure Your 65% Off Discount Now
Like our thought process here? Stop wasting time and join the community of 100s of traders at BAD BEAT Investing at a compounded 65% discount versus the regular monthly rate!
- Full access to an expert team of 4, available all day during market hours.
- Rapid-return trade ideas each week
- Target entries, profit taking, and stops rooted in technical and fundamental analysis
- Monthly deep value situations
- Stocks, options, trades, dividends, and one-on-one portfolio reviews